SLNO- Soleno Therapeutics, Inc.

Name: Soleno Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 27 buys and 17 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Anish Bhatnagar	569.5K	$30.19M	-
CFO	MacKaness James H	103.2K	$5.47M	-
Other	Joshi Manher	72.3K	$3.83M	-
Other	Manning Meredith	67.2K	$3.56M	-
Other	Norrett Kevin	64.3K	$3.41M	-

Activity

Buys and sells only

Transactions

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 29, 2023	Yen Kristen	See Remarks	Sell	7,650	$27.49	$210,326.85	-6.3%	+84.1%	+85.4%
Nov 29, 2023	MacKaness James H	Chief Financial Officer	Sell	8,081	$27.49	$222,176.75	-6.7%	+84.1%	+85.4%
Nov 29, 2023	Hirano Patricia C	See Remarks	Sell	7,381	$27.49	$202,931.18	-5.4%	+84.1%	+85.4%
Nov 29, 2023	Anish Bhatnagar	Chief Executive Officer	Sell	53,505	$27.49	$1,471,049.04	-8.0%	+84.1%	+85.4%
Sep 28, 2023	Perceptive Advisors LLC51	10% Owner	Buy	866,789	$17.44	$15,113,915.98	+2.4%	+43.1%	+78.1%
Jun 6, 2023	Perceptive Advisors LLC51	10% Owner	Buy	143,298	$5.96	$853,680.54	+2.2%	-25.3%	+692.7%
Jun 1, 2023	Perceptive Advisors LLC51	10% Owner	Buy	35,000	$5.38	$188,175.00	+0.6%	-13.1%	+615.8%
May 26, 2023	Perceptive Advisors LLC51	10% Owner	Buy	85,000	$5.29	$449,825.00	+1.4%	-8.2%	+684.0%
May 23, 2023	Perceptive Advisors LLC51	10% Owner	Buy	80,000	$5.08	$406,075.00	+1.4%	-18.3%	+693.9%
Dec 9, 2022	Schuler Jack W45	10% Owner	Sell	10,000	$0.91	$9,100.00	-21.5%	+145.5%	+4010.2%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC